The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnite Regulatory News (UTG)

Share Price Information for Unite (UTG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 958.50
Bid: 959.00
Ask: 960.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.104%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 958.50
UTG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update and Q1 Fund Valuations

8 Apr 2022 07:00

RNS Number : 7046H
Unite Group PLC (The)
08 April 2022
 

PRESS RELEASE

8 April 2022

THE UNITE GROUP PLC

('Unite Students', 'Unite', the 'Group', or the 'Company')

TRADING UPDATE AND Q1 FUND VALUATIONS

 

Unite Students, the UK's leading owner, manager and developer of student accommodation, today announces an update on current trading and quarterly property valuations for the Unite UK Student Accommodation Fund ('USAF') and the London Student Accommodation Joint Venture ('LSAV') as at 31 March 2022. 

 

Current trading

2022/23 reservations

We have seen strong progress in sales since our preliminary results, materially closing the gap to our record pre-pandemic reservations level. Across the Group's entire property portfolio, 77% of rooms are now sold for the 2022/23 academic year (2021/22:69%, 2020/21:79%). We expect strong student demand for 2022/23 from both domestic and international students with UCAS applications up 7% compared to pre-pandemic levels and reduced disruption from travel restrictions and grade inflation.

 

This is supportive of our guidance of 97% occupancy for the 2022/23 academic year and further increases our confidence in achieving rental growth of 3.0-3.5%.

 

Development pipeline update

We recently received planning approval for our 595-bed Temple Quarter development in Bristol. We intend to acquire the site in time for delivery in the 2024/25 academic year. The completed development will be fully let on a 15-year nominations agreement to the University of Bristol, further strengthening our relationship with the university.

 

In early March, our planning application for our development in Paddington, London was rejected by Westminster City Council. We are currently reviewing our options for the best route to securing planning consent for the site, however this delay now means that we will no longer deliver the scheme for the 2024/25 academic year.

 

We continue to see inflationary pressure on build costs for our development pipeline, which typically account for 50-70% of our total development costs. This reflects ongoing supply chain disruption created by the pandemic as well as rising energy and materials prices, which have been exacerbated by the war in Ukraine.

 

Our 2022 and 2023 schemes are secured under fixed price build contracts and remain in line with budget and on track for their scheduled delivery dates. However, we are seeing cost increases for schemes yet to be procured for delivery in 2024 and 2025. As a result, we now expect the yield on cost for our 2024 and 2025 schemes to be reduced by up to 20 bps, compared to our initial assumptions (previously 10-20bps). These schemes remain attractive and we will seek to mitigate the impact of increasing build costs through design efficiency and increased rental levels where possible.

 

Quarterly fund valuations

At 31 March 2022, USAF's property portfolio was independently valued at £2,865 million, a 1.7% increase on a like-for-like basis during the quarter. The valuation increase in USAF is driven by rental growth of 0.7% and a 6 basis point reduction in property yields. The portfolio comprises 28,929 beds in 71 properties across 19 university towns and cities in the UK.

 

LSAV's investment portfolio was independently valued at £1,868 million, a 2.7% increase on a like-for-like basis during the quarter. The valuation increase in LSAV is driven by rental growth of 1.1% and a 7 basis point reduction in property yields. LSAV's investment portfolio comprises 9,716 beds across 14 properties in London and Aston Student Village in Birmingham.

 

The USAF and LSAV portfolios are now valued at weighted average yields of 5.1% and 4.0% respectively.

 

Joe Lister, Unite Students Chief Financial Officer, commented:

"We continue to make good progress with bookings for the 2022/23 academic year with 77% of rooms already sold, demonstrating the strength of student demand and our success in increasing the retention of existing customers. This supports our guidance for a return to 97% occupancy and increases our confidence in delivering 3.0-3.5% rental growth for the 2022/23 academic year. In the current environment, headwinds from build cost inflation are impacting our medium-term development pipeline, but we will seek to mitigate these effects where possible."

 

ENDS

 

For further information, please contact:

 

Unite Students

Joe Lister / Michael Burt Tel: +44 117 302 7005

Unite press office Tel: +44 117 450 6300

 

Powerscourt

Justin Griffiths / Victoria Heslop Tel: +44 20 7250 1446

 

About Unite Students

Unite Students is the UK's largest owner, manager and developer of purpose-built student accommodation, serving the country's world-leading Higher Education sector. We provide homes to 74,000 students across 172 properties in 25 leading university towns and cities. We currently partner with over 60 universities across the UK.

 

Our people are driven by a common purpose: to provide a 'Home for Success' for the students who live with us. Unite's accommodation is safe and secure, high quality and affordable. Students live predominantly in ensuite study bedrooms, with rents covering all bills, insurance, 24-hour security and high-speed Wi-Fi. We also achieved a five-star British Safety Council rating in our last audit.

 

We are committed to raising standards in the student accommodation sector for our customers, investors and employees. This is why our new Sustainability Strategy, launched in 2021, includes a commitment to become net zero carbon across our operations and developments by 2030.

 

Founded in 1991 in Bristol, Unite Group is an award-winning Real Estate Investment Trust (REIT), listed on the London Stock Exchange and a member of the FTSE 250 Index. Unite is invested in and operates two specialist funds and joint ventures with institutional investment partners: the £3 billion Unite UK Student Accommodation Fund (USAF) and the £2 billion London Student Accommodation Vehicle (LSAV).

 

For more information, visit:

Unite's corporate website www.unite-group.com

The student site www.unitestudents.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSFFIWEESELL
Date   Source Headline
26th Apr 20246:00 pmRNSHolding(s) in Company
25th Apr 20245:06 pmRNSScrip Reference Share Price & Enhanced Scrip
16th Apr 20241:05 pmRNSHolding(s) in Company
15th Apr 20243:20 pmRNSPublication of Base Listing Particulars
11th Apr 202412:05 pmRNSDirector/PDMR Shareholding
10th Apr 20243:15 pmRNSDirector/PDMR Shareholding
10th Apr 20243:00 pmRNS2023 Annual Report and Notice of AGM
9th Apr 20247:00 amRNSTRADING UPDATE AND Q1 FUND VALUATIONS
28th Mar 20244:00 pmRNSTotal Voting Rights
11th Mar 20248:30 amRNSDirector Declaration
6th Mar 20249:30 amRNSDirector/PDMR Shareholding
29th Feb 20244:52 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSResults for the year ended 31 December 2023
19th Feb 20247:00 amRNSUniversity Joint Venture
31st Jan 20243:30 pmRNSTotal Voting Rights
10th Jan 20249:00 amRNSNotice of Results
9th Jan 20247:00 amRNSTRADING UPDATE AND Q4 FUND VALUATIONS
2nd Jan 202410:00 amRNSTotal Voting Rights
1st Dec 20232:00 pmRNSBlock listing Interim Review
30th Nov 20234:00 pmRNSTotal Voting Rights
16th Nov 20232:00 pmRNSDirector/PDMR Shareholding
31st Oct 20234:30 pmRNSDirector/PDMR Shareholding
31st Oct 20232:30 pmRNSTotal Voting Rights
20th Oct 20232:00 pmRNSResults of Scrip Dividend Election
5th Oct 20237:01 amRNSTrading Update and Q3 Fund Valuations
5th Oct 20237:00 amRNSCEO Succession & Board Changes
2nd Oct 20234:00 pmRNSDirector/PDMR Shareholding
29th Sep 202311:00 amRNSTotal Voting Rights
22nd Sep 202311:00 amRNSSCRIP REFERENCE SHARE PRICE-2023 INTERIM DIVIDEND
20th Sep 20232:10 pmRNSHolding(s) in Company
15th Sep 20236:31 pmRNSHolding(s) in Company
13th Sep 20237:00 amRNSNew 800-bed development in Glasgow
31st Aug 20232:00 pmRNSTotal Voting Rights
1st Aug 202310:00 amRNSHolding(s) in Company
31st Jul 20233:00 pmRNSTotal Voting Rights
27th Jul 202311:13 amRNSHolding(s) in Company
27th Jul 202311:00 amRNSDirector/PDMR Shareholding
25th Jul 20236:00 pmRNSUnite Group
25th Jul 20237:00 amRNSResults of Capital Raise
24th Jul 20234:41 pmRNSRetail offer of new ordinary shares
24th Jul 20234:40 pmRNSProposed placing of new ordinary shares
24th Jul 20234:38 pmRNSInterim Results
10th Jul 20237:00 amRNSTRADING UPDATE AND Q2 FUND VALUATIONS
30th Jun 20235:10 pmRNSTotal Voting Rights
23rd Jun 20239:00 amRNSNotice of Interim Results
21st Jun 20235:24 pmRNSHolding(s) in Company
16th Jun 20234:30 pmRNSDirector/PDMR Shareholding
12th Jun 20232:30 pmRNSAdditional Listing
1st Jun 20234:00 pmRNSDirector/PDMR Shareholding
1st Jun 202311:30 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.